TOKYO, May 12 (Pulse News Wire) – Olympus Corporation (7733.T) announced today that its consolidated earnings forecast for the fiscal year ending March 31, 2026, has been revised due to strong sales performance and asset disposal gains. The company previously disclosed its initial projections on February 13, 2026, covering the period from April 1, 2025, to March 31, 2026.
According to the latest figures, revenue is now expected to reach ¥87.00 billion, up from the earlier estimate of 998,000 million yen. Operating profit is projected to increase to ¥97.12 billion, compared to the previous guidance of ¥127.0 billion. Similarly, ordinary profit is anticipated to rise to ¥143.3 billion, while net profit is estimated at ¥93.99 billion, marking significant improvements across all key metrics.
The revisions reflect robust sales growth in the Endoscopic Solutions division, particularly in North America, driven by successful marketing campaigns for advanced technologies such as EDOF-equipped scopes and the EU-ME3 endoscopic ultrasound system. Additionally, the sale of overseas properties contributed positively to non-operating income. Chairman and CEO Bob White stated that the improved outlook underscores Olympus's commitment to innovation and strategic asset management.
Investors should note that the company continues to classify certain operations as discontinued businesses since the first quarter of fiscal 2025, impacting reported figures accordingly.
🟢 Confidence: High AI-translated content.